Fruzaqla
Active substance: fruquintinib
CAPSULE · FRUQUINTINIB 5 mg/1
United StatesActive
Marketing holder: Takeda Pharmaceuticals America, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- FRUQUINTINIB · 5 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12094-0a90-7afd-8d00-eb026a6ed971,01a12096-ae3e-7882-a62b-88e8d6428601;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 63020-225
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 63020-225 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 63020-225 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 63020-225 · Verified 2026-10-09 · open in source